EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Combination of Nirmatrelvir and Ivermectin Exerts Strongly Synergistic Antiviral and Anti-Inflammatory Effects Against Murine Coronavirus Infection of Macrophages

Wilson Z Y How, Le Xin Teh, Vincent T K Chow iD

International Journal of Molecular Sciences · 16.08.2026 · 27 (16) · 7316

DOI: 10.3390/ijms27167316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.08.2026. Verfasst von Wilson Z Y How und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Kent Ridge, Singapore 117545, Singapore. Hauptthemen laut MEDLINE: Ivermectin, Antiviral Agents, Macrophages, Anti-Inflammatory Agents. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National University of Singapore, Department of Microbiology and Immunology, National University of Singapore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of SARS-CoV-2 variants and antiviral resistance highlights the need for improved therapeutic strategies against COVID-19 and other coronavirus infections. By pairing direct-acting antivirals with repurposed host-modulating drugs, combination therapy approaches may enhance antiviral efficacy while mitigating inflammation. In this study, we evaluated the effects of combining Nirmatrelvir (a SARS-CoV-2 main protease inhibitor) with Ivermectin, Azithromycin or Doxycycline—using a murine hepatitis virus (MHV) infection model of RAW264.7 macrophages. Checkerboard assays demonstrated that the Nirmatrelvir–Ivermectin combination exhibited strongly synergistic antiviral activity. This combination achieved potent inhibition of live virus titer of at least 5 to 6 log10 and reduction in viral RNA load of 3 log10, at drug concentrations much lower than the respective monotherapies. The Nirmatrelvir–Ivermectin combination treatment affected the coronavirus replication cycle at the same time-point of 8 h as Nirmatrelvir monotherapy. Moreover, multiplex cytokine protein profiling revealed that Nirmatrelvir–Ivermectin markedly suppressed key pro-inflammatory cytokines and chemokines associated with the cytokine storm, including IL-6, TNF-α, IL-1β, and MCP-1. Conversely, the combinations of Nirmatrelvir with Azithromycin or Doxycycline exhibited only additive or mildly additive effects, with alterations in certain cytokine levels. These findings support the potential of Nirmatrelvir–Ivermectin as a promising novel combination therapy with both antiviral and anti-inflammatory benefits, warranting further in vivo validation and clinical investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IvermectinAntiviral AgentsMacrophagesAnti-Inflammatory AgentsCoronavirus InfectionsAnimalsMiceDrug SynergismMurine hepatitis virusVirus ReplicationRAW 264.7 CellsCytokinesSARS-CoV-2AzithromycinDoxycyclineDrug Therapy, Combination

Stichwörter der Autor:innen

AzithromycinDoxycyclineIvermectinNirmatrelviranti-inflammatoryantiviralcombination therapycoronavirusmurine hepatitis virusrepurposed drugs

Substanzen

IvermectinAntiviral AgentsAnti-Inflammatory AgentsCytokinesAzithromycinDoxycycline

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Kent Ridge, Singapore 117545, Singapore.
  • Infectious Diseases Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Kent Ridge, Singapore 117545, Singapore.

ORCID-Profile: Vincent T K Chow

Förderung

  • National University of Singapore
  • Department of Microbiology and Immunology, National University of Singapore

Zitieren

APA

How, W. Z. Y., Teh, L. X., & Chow, V. T. K. (2026). The Combination of Nirmatrelvir and Ivermectin Exerts Strongly Synergistic Antiviral and Anti-Inflammatory Effects Against Murine Coronavirus Infection of Macrophages. International Journal of Molecular Sciences, 27(16), 7316. https://doi.org/10.3390/ijms27167316

Vancouver

How WZY, Teh LX, Chow VTK. The Combination of Nirmatrelvir and Ivermectin Exerts Strongly Synergistic Antiviral and Anti-Inflammatory Effects Against Murine Coronavirus Infection of Macrophages. International Journal of Molecular Sciences. 2026;27(16):7316. doi:10.3390/ijms27167316

BibTeX
@article{How2026,
  author = {How, Wilson Z Y and Teh, Le Xin and Chow, Vincent T K},
  title = {The Combination of Nirmatrelvir and Ivermectin Exerts Strongly Synergistic Antiviral and Anti-Inflammatory Effects Against Murine Coronavirus Infection of Macrophages},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {16},
  pages = {7316},
  doi = {10.3390/ijms27167316}
}
Kostenlos starten →